Two-Year Experience with Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Clinical Practice. (PubMed, Am J Ophthalmol) - Sep 12, 2026 - "Pegcetacoplan therapy reduced the growth rate of GA by about 41% over 2 years and continued to show accumulated efficacy during the second year."
Journal • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
|
|
Alessandro Berni; Da Meng; Eduardo Herrera; Giovanni Gregori; Gissel Herrera; James Kastner; Jeremy Liu; Maura Di Nicola; Mengxi Shen; Omar Badla; Omar S El-Mulki; Omer Trivizki; Philip J Rosenfeld; Pratik Patel; Robert C O'Brien; Ruikang K Wang; Sander R Dubovy; Sivathanu Kumar; Viet Hoan Le; Winston Z Lam; Yi Zhang; Yuxuan Cheng; Zohar Yehoshua
|